Stock listing
B3:ALOS3F Allos S.A. Ações
Brazilian listing (B3) of Allos S.A. · home listing B3:ALOS3
Follow Allos S.A. into a list and get an email when it puts out news.
Home listing price · BMFBOVESPA:ALOS3
25.75 BRL -0.59 (-2.2%)
Close on Nov 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, BMFBOVESPA:ALOS3
- Day range
- 25.53 – 26.41 BRLNov 19, 2026
- Volume
- 6.76M sharesNov 19, 2026
- Market cap
- 12.88B BRLAt the close on Nov 19, 2026 · price × 500.1M shares outstanding
- 52-week range
- 23.00 – 36.26 BRLLowest and highest trades, Nov 21, 2025 – Nov 19, 2026
- Traded on an average day
- 224.8M BRLMedian day 6.67M shares · last 3 months, Aug 19, 2026 – Nov 19, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| B3:ALOS3 · Home | 25.75 BRL | -0.59 (-2.2%) | 6,759,400 | 26.39 | 26.41 | 25.53 | 26.34 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 19, 2026 – Nov 19, 2026 · BMFBOVESPA:ALOS3 · BRL, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 25.75 | -0.59 | -2.2% | 26.39 | 26.41 | 25.53 | 6,759,400 | |
| 26.34 | -0.08 | -0.3% | 26.60 | 26.82 | 26.18 | 4,329,100 | |
| 26.42 | -0.63 | -2.3% | 27.03 | 27.03 | 26.00 | 5,438,300 | |
| 27.05 | +0.35 | +1.3% | 26.87 | 27.22 | 26.70 | 3,570,300 | |
| 26.70 | -0.78 | -2.8% | 27.47 | 27.58 | 26.44 | 6,851,100 | |
| 27.48 | +0.59 | +2.2% | 27.04 | 27.82 | 26.96 | 7,249,300 | |
| 26.89 | -0.34 | -1.2% | 27.49 | 27.56 | 26.55 | 6,671,100 | |
| 27.23 | +0.77 | +2.9% | 26.82 | 27.48 | 26.57 | 6,079,500 | |
| 26.46 | +1.41 | +5.6% | 25.49 | 26.72 | 25.15 | 13,097,600 | |
| 25.05 | +0.19 | +0.8% | 24.93 | 25.56 | 24.71 | 8,255,900 | |
| 24.86 | +1.34 | +5.7% | 23.76 | 24.86 | 23.71 | 10,864,300 | |
| 23.52 | +0.02 | +0.1% | 23.18 | 23.66 | 23.01 | 12,172,600 | |
| 23.50 | -0.05 | -0.2% | 23.45 | 23.73 | 23.00 | 15,266,300 | |
| 23.55 | -0.96 | -3.9% | 24.60 | 24.69 | 23.47 | 15,172,100 | |
| 24.51 | -1.34 | -5.2% | 25.85 | 25.86 | 24.17 | 18,491,200 | |
| 25.85 | -0.34 | -1.3% | 26.81 | 26.81 | 25.53 | 13,677,300 | |
| 26.19 | -8.95 | -25.5% | 24.01 | 27.48 | 24.01 | 27,436,100 | |
| 35.14 | +0.29 | +0.8% | 34.81 | 35.42 | 34.25 | 7,345,900 | |
| 34.85 | -0.41 | -1.2% | 35.07 | 35.26 | 34.56 | 7,924,800 | |
| 35.26 | -0.44 | -1.2% | 35.75 | 36.26 | 35.05 | 7,292,200 | |
| 35.70 | +0.82 | +2.4% | 35.55 | 36.09 | 35.35 | 8,360,200 | |
| 34.88 | +0.38 | +1.1% | 34.70 | 35.29 | 34.54 | 5,172,100 | |
| 34.50 | -0.14 | -0.4% | 34.69 | 35.02 | 34.03 | 10,875,400 | |
| 34.64 | -0.07 | -0.2% | 34.07 | 34.92 | 33.91 | 13,319,000 | |
| 34.71 | -0.09 | -0.3% | 34.27 | 34.94 | 33.76 | 7,036,100 | |
| 34.80 | -1.03 | -2.9% | 35.60 | 35.60 | 34.64 | 6,433,900 | |
| 35.83 | +0.70 | +2.0% | 35.40 | 36.10 | 35.27 | 9,069,000 | |
| 35.13 | +0.67 | +1.9% | 34.33 | 35.57 | 34.29 | 10,428,800 | |
| 34.46 | +0.17 | +0.5% | 34.30 | 34.63 | 33.91 | 10,041,700 | |
| 34.29 | +1.23 | +3.7% | 33.32 | 34.50 | 33.16 | 11,668,500 | |
| 33.06 | +2.55 | +8.4% | 32.41 | 33.92 | 31.80 | 22,405,900 | |
| 30.51 | +0.86 | +2.9% | 30.06 | 30.59 | 29.71 | 10,273,900 | |
| 29.65 | +0.16 | +0.5% | 29.50 | 29.69 | 29.13 | 5,757,100 | |
| 29.49 | +0.72 | +2.5% | 29.32 | 29.76 | 29.01 | 11,148,000 | |
| 28.77 | +0.20 | +0.7% | 28.57 | 28.88 | 28.37 | 2,658,500 | |
| 28.57 | -0.41 | -1.4% | 28.96 | 28.96 | 28.40 | 3,408,200 | |
| 28.98 | -0.14 | -0.5% | 29.04 | 29.31 | 28.59 | 2,778,400 | |
| 29.12 | -0.22 | -0.7% | 29.49 | 29.49 | 28.87 | 3,664,800 | |
| 29.34 | -0.38 | -1.3% | 29.15 | 29.67 | 29.06 | 2,837,400 | |
| 29.72 | +0.02 | +0.1% | 29.69 | 29.83 | 29.43 | 11,646,600 | |
| 29.70 | +0.83 | +2.9% | 29.01 | 29.87 | 29.01 | 5,891,600 | |
| 28.87 | +0.58 | +2.1% | 28.15 | 28.87 | 28.05 | 5,027,400 | |
| 28.29 | -0.17 | -0.6% | 28.76 | 28.76 | 27.83 | 5,922,600 | |
| 28.46 | -0.07 | -0.2% | 28.53 | 28.81 | 28.40 | 9,049,300 | |
| 28.53 | +0.09 | +0.3% | 28.51 | 28.67 | 28.25 | 2,870,100 | |
| 28.44 | -0.19 | -0.7% | 27.91 | 28.48 | 27.82 | 4,292,700 | |
| 28.63 | -0.44 | -1.5% | 29.08 | 29.21 | 28.47 | 3,688,300 | |
| 29.07 | +0.55 | +1.9% | 28.46 | 29.21 | 28.20 | 3,944,100 | |
| 28.52 | -0.70 | -2.4% | 28.92 | 28.95 | 28.30 | 3,908,600 | |
| 29.22 | +0.41 | +1.4% | 29.32 | 29.49 | 28.96 | 5,794,500 | |
| 28.81 | -0.21 | -0.7% | 28.95 | 29.06 | 28.57 | 4,061,500 | |
| 29.02 | +0.49 | +1.7% | 29.01 | 29.62 | 28.92 | 8,780,600 | |
| 28.53 | +1.21 | +4.4% | 27.56 | 28.63 | 27.46 | 7,907,200 | |
| 27.32 | +0.63 | +2.4% | 26.86 | 27.69 | 26.72 | 8,040,900 | |
| 26.69 | +0.28 | +1.1% | 26.59 | 26.86 | 26.38 | 4,714,400 | |
| 26.41 | +0.20 | +0.8% | 26.32 | 26.44 | 25.93 | 2,344,500 | |
| 26.21 | -0.22 | -0.8% | 26.28 | 26.51 | 26.18 | 3,300,100 | |
| 26.43 | -0.13 | -0.5% | 26.66 | 26.80 | 26.26 | 3,297,900 | |
| 26.56 | +0.55 | +2.1% | 25.96 | 26.60 | 25.96 | 3,763,600 | |
| 26.01 | -0.07 | -0.3% | 25.60 | 26.14 | 25.38 | 4,226,500 | |
| 26.08 | +0.64 | +2.5% | 25.64 | 26.18 | 25.52 | 4,158,000 | |
| 25.44 | -0.23 | -0.9% | 25.49 | 25.88 | 25.28 | 3,484,200 | |
| 25.67 | +0.30 | +1.2% | 25.84 | 26.01 | 25.30 | 6,382,100 |
- Ticker
- B3:ALOS3F
- Asset type
- Stock
- Sector
- Real estate
- Industry
- Property owners & REITs
- Exchange
- B3
- Currency
- BRL
What changed lately
Latest news release · May 8, 2026
Sales accelerate in 1Q26 and grow 6.6%¹
Latest news
Sales accelerate in 1Q26 and grow 6.6%¹
May 8, 2026
Closed 30.35 (+0.2%) on May 8, 2026
Dados Econômico-Financeiros
May 7, 2026
Closed 30.35 (+0.2%) on May 8, 2026
Acordo de Acionistas
Apr 17, 2026
Closed 33.50 (-0.9%) on Apr 20, 2026
EBITDA grows 7.5% achieving a record margin of 79%
Mar 10, 2026
Closed 30.23 (-2.1%) on Mar 11, 2026
Allos Raises $5M to Apply Causal AI Across Complex Drug Reformulation
Jan 12, 2026
Closed 29.43 (+0.6%) on Jan 12, 2026
Allos S.A. on 6ix
- Sector
- Real estate
- Industry
- Property owners & REITs
- News releases
- 5 in the last 12 months · 8 in all · newest May 8, 2026 · oldest 2025
Where Allos S.A. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| B3:ALOS3 · Home listing | B3 | Brazil | BRL |
| B3:ALOS3F · This page | B3 | Brazil | BRL |
Valuation
P/E 13.8× against a median of 10.1×: 8th lowest of 11 Property owners & REITs companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 19, 2026
- Enterprise value
- 16.76B BRL
- P/E
- 13.8×
- EV/sales
- 5.8×
- EV/EBITDA
- 8.9×
- Price/book
- 1.0×
- Gross margin
- 46.5%
- Operating margin
- 43.9%
- Net margin
- 32.3%
- Debt to equity
- 0.6×
- Beta
- No index for this market yet
Property owners & REITs: the 10 companies nearest in size, of 597 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Allos S.A. · BMFBOVESPA:ALOS3 | US$2.18B | US$2.84B | 13.8× | 5.8× | 8.9× | 1.0× | 32.3% | 0.6× | n/a |
| Redefine Properties Limited · JSE:RDF | US$2.27B | US$4.57B | 5.5× | 7.1× | 11.3× | 0.7× | 64.0% | 0.7× | n/a |
| Carmila SA · EURONEXT:CARM | US$2.27B | US$5.21B | 11.1× | 8.3× | 13.9× | 0.6× | 32.3% | 0.8× | n/a |
| Sunstone Hotel Investors, Inc. · NYSE:SHO | US$2.25B | US$2.97B | 27.0× | 3.0× | 12.9× | 1.3× | 8.3% | 0.5× | 0.60 |
| Investis Holding SA · SIX:IREN | US$2.23B | US$2.97B | 12.3× | 31.2× | 46.8× | 1.3× | 190.5% | 0.4× | n/a |
| Multiplan Empreendimentos Imobiliarios SA · BMFBOVESPA:MULT3 | US$2.19B | US$2.81B | 8.3× | 4.9× | 6.6× | 1.9× | 45.3% | 0.7× | n/a |
| SmartStop Self Storage REIT, Inc. · NYSE:SMA | US$2.14B | US$3.26B | 65.8× | 10.3× | 21.6× | 1.9× | 10.3% | 1.0× | 0.45 |
| Wallenstam AB Class B · OMXSTO:WALL_B | US$2.10B | US$5.41B | 7.3× | 16.5× | 26.9× | 0.6× | 87.5% | 1.0× | n/a |
| Wihlborgs Fastigheter AB · OMXSTO:WIHL | US$2.09B | US$5.54B | 9.0× | 12.3× | n/a | 0.9× | 52.0% | 1.4× | n/a |
| Vincom Retail JSC · HOSE:VRE | US$2.08B | US$2.13B | 7.2× | 5.8× | 9.7× | 1.1× | 79.1% | 0.1× | n/a |
| Primaris Real Estate Investment Trust · TSX:PMZ.UN | US$2.08B | US$3.75B | 25.4× | 7.5× | 17.1× | 1.1× | 16.3% | 1.0× | 0.34 |
| Median of the others | US$2.17B | US$3.50B | 10.1× | 7.9× | 13.9× | 1.1× | 48.6% | 0.8× | 0.45 |
Forecasts
Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.
- Price target
- 36.58 BRL · Analysts' mean
- EPS, year to Dec 2026
- 1.61 · 1 analyst
- Revenue, year to Dec 2026
- 3.02B · 2 analysts
Team and board
| Officer | Role |
|---|---|
| Aditya V. Iyer DPhil. | Chief Executive Officer |
| Isaac Z. To | Chief Operating Officer |
| Balu Iyer | Chief Pharma Officer |
| Ivano Lodato | Chief Scientist |
| Rajiv Lochan | Chief Chemist |
| Rich Myer | Chief Commercial Officer |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 5, 2026 · After close | +5.6% |
| Q2 2026 | Aug 6, 2026 · After close | −0.2% |
| Q1 2026 | May 7, 2026 · After close | +0.2% |
| Q4 2025 | Mar 10, 2026 · After close | −2.1% |
| Q3 2025 | Nov 12, 2025 · After close | +4.6% |
| Q2 2025 | Aug 12, 2025 · After close | −0.4% |
| Q1 2025 | May 14, 2025 · After close | +1.5% |
| Q3 2024 | Nov 12, 2024 · After close | +1.1% |
| Q2 2024 | Aug 13, 2024 · After close | +1.4% |
| Q1 2024 | May 9, 2024 · After close | +3.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Mar 20, 2024 · After close | −1.0% |
| Q3 2023 | Nov 13, 2023 · After close | +2.6% |
| Q2 2023 | Aug 13, 2023 · After close | −2.0% |
| Q1 2023 | May 14, 2023 · After close | +1.2% |
| Q3 2022 | Nov 9, 2022 · After close | −9.3% |
| Q2 2022 | Aug 10, 2022 · After close | −2.2% |
| Q1 2022 | May 10, 2022 · After close | +0.9% |
| Q3 2021 | Nov 10, 2021 · After close | +5.1% |
| Quarter to Jun 30, 2021 | Aug 11, 2021 · After close | −2.9% |
| Quarter to Dec 31, 2020 | Mar 8, 2021 · After close | −0.6% |
Financials
Annual, in BRL
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.86B | 2.74B | 2.71B | 1.11B | 937.7M | 797.6M | 743.2M | 508.4M | 354.9M | 342.3M |
| Cost of revenue | 1.51B | 719.0M | 826.9M | 310.0M | 300.8M | 269.5M | 200.1M | 122.8M | 83.1M | 84.4M |
| Gross profit | 1.35B | 2.02B | 1.89B | 801.3M | 636.9M | 528.0M | 543.1M | 385.6M | 271.7M | 257.9M |
| Selling, general and administrative | 111.4M | 121.6M | 119.5M | 43.7M | 29.0M | 30.4M | 23.6M | 17.6M | 27.9M | 29.5M |
| Operating income | 1.37B | 1.45B | 5.41B | 469.6M | 490.1M | 259.6M | 277.2M | 560.3M | 382.4M | 386.4M |
| Depreciation and amortization | 624.0M | 618.8M | 684.5M | 202.1M | 191.1M | 185.5M | 118.9M | 72.0M | 2.29M | 2.65M |
| EBITDA | 1.99B | 2.07B | 6.10B | 671.7M | 681.2M | 445.1M | 396.1M | 632.3M | 384.7M | 389.1M |
| Interest expense | 960.2M | 726.5M | 756.5M | 306.6M | 194.8M | 80.4M | 105.9M | 116.5M | 78.7M | 96.7M |
| Income before tax | 1.02B | 868.2M | 4.91B | 255.2M | 339.9M | 266.3M | 104.5M | 160.1M | 319.1M | 323.3M |
| Income tax | 72.3M | 56.2M | 1.41B | 33.1M | 21.5M | 63.8M | 47.8M | 40.6M | 66.9M | 75.5M |
| Net income | 834.2M | 698.5M | 3.39B | 155.9M | 274.9M | 169.1M | 22.0M | 114.0M | 138.4M | 96.3M |
| Earnings per share, basic | 1.64 | 1.29 | 6.05 | 0.59 | 1.04 | 0.64 | 0.10 | 0.55 | 1.81 | 1.26 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 60.6M | 47.8M | 44.3M | 18.3M | 14.9M | 13.1M | 32.7M | 21.9M | 448.4M | 256.0M |
| Short-term investments | 2.37B | 3.32B | 2.09B | 2.54B | 1.23B | 1.37B | 1.17B | 550.7M | ||
| Receivables | 700.3M | 492.8M | 647.1M | 323.2M | 400.5M | 327.5M | 169.0M | 97.6M | 53.6M | 51.4M |
| Inventory | -492.8M | |||||||||
| Current assets | 3.15B | 4.27B | 3.82B | 3.27B | 1.78B | 1.85B | 1.54B | 811.9M | 541.7M | 344.4M |
| Property, plant and equipment | 106.6M | 97.4M | 87.0M | 20.0M | 26.5M | 10.4M | 3.21M | |||
| Goodwill | 324.8M | 336.5M | 336.5M | 207.5M | 207.5M | 225.8M | 226.1M | 224.2M | ||
| Total assets | 26.0B | 27.3B | 27.7B | 12.3B | 11.1B | 10.9B | 10.9B | 4.74B | 5.33B | 4.99B |
| Accounts payable | 85.9M | 89.9M | 91.5M | 36.5M | 34.2M | 30.3M | 33.9M | 15.3M | 3.98M | 6.15M |
| Current liabilities | 352.4M | 2.27B | 2.14B | 1.02B | 727.5M | 423.7M | 239.5M | 189.1M | 316.6M | 224.9M |
| Long-term debt | 5.55B | 5.52B | 5.04B | 2.39B | 1.56B | 1.77B | 2.08B | 567.2M | ||
| Total debt | 6.10B | 6.82B | 5.87B | 3.09B | 2.07B | 2.06B | 2.18B | 1.88B | 974.4M | 814.4M |
| Total liabilities | 12.1B | 13.2B | 12.6B | 4.41B | 3.30B | 3.27B | 3.39B | 2.14B | 1.71B | 1.53B |
| Shareholders' equity | 13.1B | 13.4B | 14.0B | 6.81B | 6.75B | 6.54B | 6.44B | 2.55B | 2.59B | 2.48B |
| Shares outstanding | 507.2M | 543.0M | 559.5M | 265.0M | 265.2M | 264.7M | 217.7M | 206.1M | 76.4M | 76.4M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1.03B | 1.68B | 1.44B | 929.7M | 600.2M | 303.9M | 502.9M | 374.9M | 170.9M | 162.7M |
| Capital spending | -26.3M | -137.1M | -108.6M | -95.2M | -68.2M | -29.3M | -13.8M | -13.8M | -2.26M | -1.25M |
| Free cash flow | 1.00B | 1.54B | 1.33B | 834.5M | 532.0M | 274.6M | 489.1M | 361.0M | 168.7M | 161.5M |
| Cash from investing | 1.28B | 87.8M | 359.5M | -1.39B | -309.2M | -38.9M | -807.6M | 38.0M | -16.5M | 25.9M |
| Cash from financing | -2.30B | -1.76B | -1.78B | 461.2M | -289.3M | -284.6M | 315.5M | -397.5M | 37.9M | -197.8M |
| Dividends paid | -708.0M | -761.8M | -292.9M | -102.0M | -60.0M | -85.6M | -23.6M | -34.8M | -34.8M | |
| Share buybacks | -159.8M | -1.01B | -340.5M | 5.83M | 246.0K | -36.9M | -15.0M | -13.0M | ||
| Change in cash | 12.8M | 3.45M | 26.1M | 3.39M | 1.75M | -19.6M | 10.8M | 15.3M | 192.4M | -9.10M |
Cap table
Built by 6ix from Allos S.A.’s releases
- Common shares
- 500,139,325
- Fully diluted
- 500,139,325
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 500,139,325 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 500,139,325 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Aditya V. Iyer DPhil. | Chief Executive Officer · Since at least Nov 5, 2026 |
| Balu Iyer | Chief Pharma Officer · Since at least Nov 5, 2026 |
| Isaac Z. To | Chief Operating Officer · Since at least Nov 5, 2026 |
| Ivano Lodato | Chief Scientist · Since at least Nov 5, 2026 |
| Rajiv Lochan | Chief Chemist · Since at least Nov 5, 2026 |
| Rich Myer | Chief Commercial Officer · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Allos S.A.